LONDON (Reuters) - A simple "see and treat" approach using a test costing $2 could help doctors prevent 100,000 cervical cancer deaths a year in women in poorer countries, British scientists said on Friday. Cervical cancer is the leading cause of cancer death among women in developing nations where the main barriers to tackling the disease are poor health service ...

As the economy falters and more people go without health insurance, low-income women in at least 20 states are being turned away or put on long waiting lists for free cancer screenings, according to the American Cancer Society's Cancer Action Network. In the unofficial survey of ...

Enzo Biochem Inc. said Thursday it signed a marketing deal covering New York and New Jersey with Ikonisys Inc. for a molecular cervical cancer test. Financial terms were not disclosed. Under the deal, New Haven, Conn.-based Enzo will market Ikonisys' tests. Enzo provides diagnostic services and makes research ...